PRP Medical Services Ltd - Accounts to registrar (filleted) - small 18.2

PRP Medical Services Ltd - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v19.3.2.199 10215919 Board of Directors 1.7.18 30.6.19 30.6.19 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 531 140 136646 98292 137151 97901 26 531 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure102159192018-06-30102159192019-06-30102159192018-07-012019-06-30102159192017-06-30102159192017-07-012018-06-30102159192018-06-3010215919ns15:EnglandWales2018-07-012019-06-3010215919ns14:PoundSterling2018-07-012019-06-3010215919ns10:Director12018-07-012019-06-3010215919ns10:PrivateLimitedCompanyLtd2018-07-012019-06-3010215919ns10:SmallEntities2018-07-012019-06-3010215919ns10:AuditExempt-NoAccountantsReport2018-07-012019-06-3010215919ns10:SmallCompaniesRegimeForDirectorsReport2018-07-012019-06-3010215919ns10:SmallCompaniesRegimeForAccounts2018-07-012019-06-3010215919ns10:FullAccounts2018-07-012019-06-3010215919ns10:OrdinaryShareClass12018-07-012019-06-3010215919ns10:OrdinaryShareClass22018-07-012019-06-3010215919ns10:OrdinaryShareClass32018-07-012019-06-3010215919ns10:Director2422018-06-3010215919ns10:Director2422017-06-3010215919ns10:Director2422018-07-012019-06-3010215919ns10:Director2422017-07-012018-06-3010215919ns10:Director2422019-06-3010215919ns10:Director2422018-06-3010215919ns5:CurrentFinancialInstruments2019-06-3010215919ns5:CurrentFinancialInstruments2018-06-3010215919ns5:ShareCapital2019-06-3010215919ns5:ShareCapital2018-06-3010215919ns5:RetainedEarningsAccumulatedLosses2019-06-3010215919ns5:RetainedEarningsAccumulatedLosses2018-06-301021591912018-07-012019-06-3010215919ns5:PlantMachinery2018-06-3010215919ns5:PlantMachinery2018-07-012019-06-3010215919ns5:PlantMachinery2019-06-3010215919ns5:PlantMachinery2018-06-3010215919ns5:CurrentFinancialInstrumentsns5:WithinOneYear2019-06-3010215919ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-06-3010215919ns10:OrdinaryShareClass12019-06-3010215919ns10:OrdinaryShareClass22019-06-3010215919ns10:OrdinaryShareClass32019-06-3010215919ns10:Director22018-07-012019-06-3010215919ns10:Director112018-06-3010215919ns10:Director112017-06-3010215919ns10:Director112018-07-012019-06-3010215919ns10:Director112017-07-012018-06-3010215919ns10:Director112019-06-3010215919ns10:Director112018-06-30


REGISTERED NUMBER: 10215919 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 June 2019

for

PRP Medical Services Ltd

PRP Medical Services Ltd (Registered number: 10215919)






Contents of the Financial Statements
for the Year Ended 30 June 2019




Page

Balance Sheet 1

Notes to the Financial Statements 3


PRP Medical Services Ltd (Registered number: 10215919)

Balance Sheet
30 June 2019

2019 2018
Notes £    £   
FIXED ASSETS
Tangible assets 4 1,977 712

CURRENT ASSETS
Debtors 5 83,953 40,269
Cash at bank 9,842 64,832
93,795 105,101
CREDITORS
Amounts falling due within one year 6 (31,908 ) (38,111 )
NET CURRENT ASSETS 61,887 66,990
TOTAL ASSETS LESS CURRENT
LIABILITIES

63,864

67,702

PROVISIONS FOR LIABILITIES (376 ) (135 )
NET ASSETS 63,488 67,567

CAPITAL AND RESERVES
Called up share capital 7 101 101
Retained earnings 63,387 67,466
SHAREHOLDERS' FUNDS 63,488 67,567

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2019 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and
387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the
company as at the end of each financial year and of its profit or loss for each financial year in
accordance with the requirements of Sections 394 and 395 and which otherwise comply with
the requirements of the Companies Act 2006 relating to financial statements, so far as
applicable to the company.

PRP Medical Services Ltd (Registered number: 10215919)

Balance Sheet - continued
30 June 2019


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors on 30 March 2020 and were
signed on its behalf by:





Dr P Pietrzak - Director


PRP Medical Services Ltd (Registered number: 10215919)

Notes to the Financial Statements
for the Year Ended 30 June 2019

1. STATUTORY INFORMATION

PRP Medical Services Ltd is a private company, limited by shares , registered in England
and Wales. The company's registered number and registered office address are as below:

Registered number: 10215919

Registered office: 49 Peter Street
Manchester
M2 3NG

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make
judgements, estimates and assumptions about the carrying amount of assets and liabilities
that are not readily apparent from other sources. The estimates and associated assumptions
are based on historical experience and other factors that are considered to be relevant.
Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to
accounting estimates are recognised in the period in which the estimate is revised where the
revision affects only that period, or in the period of the revision and future periods where the
revision affects both current and future periods.

There have been no critical judgements, estimates or assumptions made in the preparation
of these financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding
discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

PRP Medical Services Ltd (Registered number: 10215919)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2019

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible Fixed assets are initially measured at cost and subsequently measured at cost or
valuation, net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual
values over their useful lives on the following basis:

Fixtures and Fittings - 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between
the sale proceeds and the carrying value of the asset, and is credited or charged to the profit
or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement
of Income and Retained Earnings, except to the extent that it relates to items recognised in
other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that
have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not
reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in
periods different from those in which they are recognised in financial statements. Deferred
tax is measured using tax rates and laws that have been enacted or substantively enacted
by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it
is probable that they will be recovered against the reversal of deferred tax liabilities or other
future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2018 - 2 ) .

PRP Medical Services Ltd (Registered number: 10215919)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2019

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 July 2018 949
Additions 2,004
At 30 June 2019 2,953
DEPRECIATION
At 1 July 2018 237
Charge for year 739
At 30 June 2019 976
NET BOOK VALUE
At 30 June 2019 1,977
At 30 June 2018 712

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Trade debtors 83,953 40,269

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Taxation and social security 29,095 34,638
Other creditors 2,813 3,473
31,908 38,111

7. CALLED UP SHARE CAPITAL




Allotted, issued and fully paid:
Number: Class: Nominal 2019 2018
value: £    £   
60 Ordinary A £1 60 60
40 Ordinary B £1 40 40
1 Ordinary C £1 1 1
101 101

PRP Medical Services Ltd (Registered number: 10215919)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2019

7. CALLED UP SHARE CAPITAL - continued

The A Shares confer on the holders the right to vote upon any resolution proposed at any
general meeting of the company.

The B and C Shares do not confer on the holders the right to vote upon any resolution
proposed at any general meeting of the company.

The A, B and C Shares rank pari passu in respect of dividend and capital distribution rights.

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended
30 June 2019 and 30 June 2018:

2019 2018
£    £   
Dr P Pietrzak and Mrs R Himpson
Balance outstanding at start of year 531 140
Amounts advanced 136,646 98,292
Amounts repaid (137,151 ) (97,901 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 26 531

The loan is repayable on demand and no interest was charged during the year.

9. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Dr Pietrzak by virtue of holding 100% of the voting Share
Capital.